A homologous series of dinuclear compounds with the bridging ligand 2-(2-pyridyl)-1,8-naphthyridine (pynp) has been prepared and characterized by X-ray crystallographic and spectroscopic methods. [Mo2(O2CCH3)2(pynp)2][BF4]2·3CH3CN (1) crystallizes in the monoclinic space group P21/c with a = 15.134(5) Å, b = 14.301(6) Å, c = 19.990(6) Å, # = 108.06(2)°, V = 4113(3) ų, and Z = 4. [Ru2(O2CCH3)2(pynp)2][PF6]2·2CH3OH (2) crystallizes in the monoclinic space group C2/c with a = 14.2228(7) Å, b = 20.3204(9) Å, c = 14.1022(7) Å, # = 95.144(1)°, V = 4059.3(3) ų, and Z = 4. [Rh2(O2CCH3)2(pynp)2][BF4]2·C7H8 (3) crystallizes in the monoclinic space group C2/c with a = 13.409(2) Å, b = 21.670(3) Å, c = 13.726(2) Å, # = 94.865(2)°, V = 3973.9(8) ų, and Z = 4. A minor product, [Rh2(O2CCH3)2(pynp)2(CH3CN)2][BF4][PF6]·2CH3CN (4), was isolated from the mother liquor after crystals of 3 had been harvested; this compound crystallizes in the triclinic space group, P&onemacr; with a = 12.535(3) Å, b = 13.116(3) Å, c = 13.785(3) Å, ! = 82.52(3)°, # = 77.70(3)°, % = 85.76(3)°, V = 2193.0(8) ų, and Z = 2. Compounds 1m3 constitute a convenient series for probing the influence of the electronic configuration on the extent of mixing of the MmM orbitals with the ? system of the pynp ligand. Single point energy calculations performed on 1m3 at the B3LYP level of theory lend insight into the bonding in these compounds and allow for correlations to be made with electronic spectral data. Although purely qualitative in nature, the values for normalized change in orbital energies (NCOE) of the frontier orbitals before and after reduction are in agreement with the observed differences in reduction potentials as determined by cyclic voltammetry.